Cargando…

Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy

Cardiac hypertrophy, a stereotypic cardiac response to increased workload, ultimately progresses to severe contractile dysfunction and uncompensated heart failure without appropriate intervention. Sustained cardiac overload inevitably results in high energy consumption, thus breaking the balance bet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Dan, Liu, Han-Qing, Liu, Fang-Yuan, Guo, Zhen, An, Peng, Wang, Ming-Yu, Yang, Zheng, Fan, Di, Tang, Qi-Zhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804293/ https://www.ncbi.nlm.nih.gov/pubmed/35118147 http://dx.doi.org/10.3389/fcvm.2021.822969

Ejemplares similares

Mitochondria-associated endoplasmic reticulum membranes and cardiac hypertrophy: Molecular mechanisms and therapeutic targets
por: Luan, Yi, et al.
Publicado: (2022)

A high-throughput drug screening identifies luteolin as a therapeutic candidate for pathological cardiac hypertrophy and heart failure
por: Wang, Zhenya, et al.
Publicado: (2023)

Hispidulin Attenuates Cardiac Hypertrophy by Improving Mitochondrial Dysfunction
por: Wang, Yan, et al.
Publicado: (2020)

Lysosomal-Associated Protein Transmembrane 5 Functions as a Novel Negative Regulator of Pathological Cardiac Hypertrophy
por: Gao, Lu, et al.
Publicado: (2021)

Key Player in Cardiac Hypertrophy, Emphasizing the Role of Toll-Like Receptor 4
por: Xiao, Zheng, et al.
Publicado: (2020)

miR-208a in Cardiac Hypertrophy and Remodeling
por: Huang, Xing-Huai, et al.
Publicado: (2021)

NEU1 Regulates Mitochondrial Energy Metabolism and Oxidative Stress Post-myocardial Infarction in Mice via the SIRT1/PGC-1 Alpha Axis
por: Guo, Zhen, et al.
Publicado: (2022)

Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart Failure
por: Yan, Youchen, et al.
Publicado: (2022)

Toll-like receptors in cardiac hypertrophy
por: Zhang, Yanan, et al.
Publicado: (2023)

NAP1L5 Promotes Nucleolar Hypertrophy and Is Required for Translation Activation During Cardiomyocyte Hypertrophy
por: Guo, Ningning, et al.
Publicado: (2021)

Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure
por: Gogiraju, Rajinikanth, et al.
Publicado: (2019)

Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors
por: Han, Yu, et al.
Publicado: (2022)

Roles of histone acetylation sites in cardiac hypertrophy and heart failure
por: Funamoto, Masafumi, et al.
Publicado: (2023)

FABP3 Deficiency Exacerbates Metabolic Derangement in Cardiac Hypertrophy and Heart Failure via PPARα Pathway
por: Zhuang, Lingfang, et al.
Publicado: (2021)

A meta-analysis of the diagnostic value of microRNA for hypertensive left ventricular hypertrophy
por: Fei, Su-Hai, et al.
Publicado: (2022)

Insights Into the Role of Mitochondria in Vascular Calcification
por: Zeng, ZL, et al.
Publicado: (2022)

Contrast-enhanced echocardiographic diagnosis of benign and malignant cardiac tumors and its correlation with pathology
por: Yang, Zihao, et al.
Publicado: (2023)

Impact of polyphenols on heart failure and cardiac hypertrophy: clinical effects and molecular mechanisms
por: Hedayati, Neda, et al.
Publicado: (2023)

Machine learning-based investigation of the relationship between immune status and left ventricular hypertrophy in patients with end-stage kidney disease
por: Yang, Min, et al.
Publicado: (2023)

Protective Effects of Thyroid Hormone Deprivation on Progression of Maladaptive Cardiac Hypertrophy and Heart Failure
por: Kerp, Helena, et al.
Publicado: (2021)

Cardiac “hypertrophy” phenotyping: differentiating aetiologies with increased left ventricular wall thickness on echocardiography
por: Ferkh, Aaisha, et al.
Publicado: (2023)

Loss of m(6)A Methyltransferase METTL5 Promotes Cardiac Hypertrophy Through Epitranscriptomic Control of SUZ12 Expression
por: Han, Yanchuang, et al.
Publicado: (2022)

TANK Promotes Pressure Overload Induced Cardiac Hypertrophy via Activating AKT Signaling Pathway
por: Pang, Yanan, et al.
Publicado: (2021)

Modelling the pathology and treatment of cardiac fibrosis in vascularised atrial and ventricular cardiac microtissues
por: Reyat, Jasmeet S., et al.
Publicado: (2023)

Phenotypic plasticity of vascular smooth muscle cells in vascular calcification: Role of mitochondria
por: Liu, Yan Zhong, et al.
Publicado: (2022)

Downregulation of PTEN Promotes Autophagy via Concurrent Reduction in Apoptosis in Cardiac Hypertrophy in PPAR α(−/−) Mice
por: Kumari, Ritu, et al.
Publicado: (2022)

Multimodality imaging in diagnosing lipomatous atrial septal hypertrophy with atrial septal defect: a case report
por: Yu, Yi, et al.
Publicado: (2023)

Two-dimensional strain profiles in patients with physiological and pathological hypertrophy and preserved left ventricular systolic function: a comparative analyses
por: Afonso, Luis, et al.
Publicado: (2012)

Spatial Heterogeneity of Cx43 is an Arrhythmogenic Substrate of Polymorphic Ventricular Tachycardias during Compensated Cardiac Hypertrophy in Rats
por: Boulaksil, Mohamed, et al.
Publicado: (2016)

Deep learning assessment of left ventricular hypertrophy based on electrocardiogram
por: Zhao, Xiaoli, et al.
Publicado: (2022)

Cardiac Repair With Echocardiography-Guided Multiple Percutaneous Left Ventricular Intramyocardial Injection of hiPSC-CMs After Myocardial Infarction
por: Wu, Xun, et al.
Publicado: (2021)

MicroRNA-Related Strategies to Improve Cardiac Function in Heart Failure
por: Zhou, Huatao, et al.
Publicado: (2021)

Case Report: Successful surgical management of a challenging primary cardiac angiosarcoma
por: Li, Yichen, et al.
Publicado: (2023)

Cardiac-specific renalase overexpression alleviates CKD-induced pathological cardiac remodeling in mice
por: Wang, Yi, et al.
Publicado: (2022)

Pathological Cluster Identification by Unsupervised Analysis in 3,822 UK Biobank Cardiac MRIs
por: Zheng, Qiao, et al.
Publicado: (2020)

Non-coding RNAs to regulate cardiomyocyte proliferation: A new trend in therapeutic cardiac regeneration
por: Qin, Kele, et al.
Publicado: (2022)

Genetic Variants Associated With Sudden Cardiac Death in Victims With Single Vessel Coronary Artery Disease and Left Ventricular Hypertrophy With or Without Fibrosis
por: Vähätalo, Juha H., et al.
Publicado: (2022)

Management of high-output cardiac failure caused by head and neck AVMs: Percutaneous suture-assisted ethanol and coil embolotherapy
por: Wen, Ming-zhe, et al.
Publicado: (2022)

IL-6/STAT3 Signaling Promotes Cardiac Dysfunction by Upregulating FUNDC1-Dependent Mitochondria-Associated Endoplasmic Reticulum Membranes Formation in Sepsis Mice
por: Jiang, Tao, et al.
Publicado: (2022)

Correlation Between Liver Stiffness and Diastolic Function, Left Ventricular Hypertrophy, and Right Cardiac Function in Patients With Ejection Fraction Preserved Heart Failure
por: Zhang, Junyi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1bc3hob2c2mb9e6s095pqnp9ph